A case of atypical heart failure

Czech version

Authors: J. Brotánek
Authors‘ workplace: II. interní klinika, Fakultní Thomayerova nemocnice, Praha
Published in: Kardiol Rev Int Med 2011, 13(2): 121-122
Category: Case Report

Overview

We present a case of a male patient with chronic heart failure with underlying ischemic heart disease complicated by intracardiac thrombosis. We show a positive effect of reduced heart rate on angina and chronic heart failure.

Keywords:
IHD – chronic heart failure – heart rate – ivabradine

Sources

1. Špinar J, Hradec J, Meluzin J et al. Doporučení pro diagnostiku a léčbu chronického srdečního selhání ČKS 2006. Cor et Vasa 2007; 49: Kardio: K5–K34.

2. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10: 933–989.

3. Hradec J. Ivabradin v léčbě pacientů s chronickým srdečním selháním a vliv srdeční frekvence – studie SHIFT. Farmakoterapie 2011; 7: 28–31.

4. Fox K, Ford I, Steg PG et al. BEAUTIFUL Investigators. Ivabradine for patiens with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo controlled trial. Lancet 2008; 372: 807–816.

5. Swedberg K, Komajda M, Böhm M et al. SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomisedplacebo-controlled study. Lancet 2010; 376: 875–885.

6. Vítovec J, Špinar J. Studie SHIFT (The Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial) a její význam pro léčbu srdečního selhání. Kardiol Rev 2010; 12: 125–127.

7. Vítovec J, Špinar J. Snížení srdeční frekvence u srdečního selhání – studie SHIFT. Postgrad Med 2011; 13: 140–143.

Labels

Paediatric cardiology Internal medicine Cardiac surgery Cardiology

Prediction and prevention of cardiovascular risk of obesity, personalized obesity treatment

Prediction and prevention of atherosclerosis and personalized treatment of dyslipidemia

Prediction and prevention of diabetes mellitus type 2

Individualized therapy of arterial hypertension

Tabacco smoking and personalized approach in prevention and treatment

ROCKET AF study – Is the end of warfarin coming?

Patients with high cardiovascular risk in outpatient care in Slovakia: lessons from the NEMESYS and STAIRS studies

Thrombosis of mitral annulus as an early complication following mechanical replacement of mitral and aortal valves: case report

Article was published in

Cardiology Review

2011 Issue 2